Dade Behring 4Q profit drops |
|
|
|
Published
:
Wed, 14 Feb 2007 15:01
|
DEERFIELD, Ill. (AP) - Dade Behring Holdings Inc., which makes and markets diagnostics products and services to clinical laboratories, said Wednesday fourth-quarter profit fell 44 percent, as the company's restructuring drew down results.Quarterly earnings declined to $19.3 million, or 23 cents per share, from $34.3 million, or 38 cents per share during the same period in 2005.The results included a charge of $21 million, or 15 cents per share, related to the company's restructuring. Excluding the item, the company earned 38 cents per share in the period.Analysts polled by Thomson Financial forecast a profit of 37 cents per share. Thomson estimates usually exclude special items.Revenue rose 8 percent to $455.4 million from $420.8 million during the same period a year earlier. Analysts expected revenue of $450.1 million.The company said its revenue came mostly from sales of its Dimension chemistry and immunochemistry family of products, and cardiovascular and hemostasis testing. U.S. revenue grew 5 percent compared with the same period a year earlier, while sales outside the U.S. rose 4.9 percent.Annual earnings fell 4 percent to $120 million, or $1.36 per share, from $124.9 million, or $1.36 per share in 2005. Shares outstanding at the end of 2006 totaled 88 million versus 91.9 million outstanding at the end of 2005.Revenue rose 5 percent to $1.74 billion from $1.66 billion.Copyright 2006 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
|
|
|
|
Print this Story
Dade Behring sets quarterly dividend 